Client & Alumni News

OraSure lands up to $10M contract for rapid Ebola test

OraSure Technologies Inc. was awarded a three-year contract for up to $10.4 million in funding from the U.S. Department of Health and Human Services to advance clinical development of a rapid antigen test for Ebola. Orasure’s OraQuick Ebola Rapid Antigen Test can be used in a doctor’s office, hospital, clinic or field setting and can provide results within 20 minutes. The test could be crucial in containing Ebola outbreaks. Read more: